Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

JOURNAL ARTICLE published February 2018 in The Lancet

Authors: Thomas Powles | Ignacio Durán | Michiel S van der Heijden | Yohann Loriot | Nicholas J Vogelzang | Ugo De Giorgi | Stéphane Oudard | Margitta M Retz | Daniel Castellano | Aristotelis Bamias | Aude Fléchon | Gwenaëlle Gravis | Syed Hussain | Toshimi Takano | Ning Leng | Edward E Kadel | Romain Banchereau | Priti S Hegde | Sanjeev Mariathasan | Na Cui | Xiaodong Shen | Christina L Derleth | Marjorie C Green | Alain Ravaud